About KO-MED Centra Kliniczne
"Naszą misją jest ułatwianie dostępu do nowoczesnych terapii leczniczych. Nowe leki to szansa na poprawę jakości życia dla pacjenta i przyszłych pokoleń. KO-MED Centra Kliniczne to sieć nowoczesnych i prężnie działających ośrodków, które każdego dnia przyjmują dziesiątki pacjentów z całej Polski. Naszą misją jest realizacja projektów badawczych, które stanowią szansę na odzyskanie zdrowia i przyczyniają się do rozwoju medycyny. Działalność prowadzimy od 20 lat, mając na koncie setki przeprowadzonych badań klinicznych. KO-MED Centra Kliniczne to gwarancja wysokiej jakości, efektywności i bezpieczeństwa prowadzonych badań. Na pierwszym miejscu zawsze stawiamy dobro pacjenta."
Clinical Trials at KO-MED Centra Kliniczne
During the past decade, KO-MED Centra Kliniczne conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "KO-MED Centra Kliniczne"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at KO-MED Centra Kliniczne
According to Clinical.Site data, the most researched conditions in "KO-MED Centra Kliniczne" are
"Chronic Lymphocytic Leukemia" (1 trials), "Hormone-Dependent Prostate Cancer" (1 trials), "Lymphoma" (1 trials), "Non Hodgkin Lymphoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "KO-MED Centra Kliniczne" in a lesser frequency.
Clinical Trials Intervention Types at KO-MED Centra Kliniczne
Most popular intervention types in "KO-MED Centra Kliniczne" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine" (1 trials), "Bicalutamide" (1 trials), "HMPL-523" (1 trials), "HMPL-689" (1 trials) and "Irinotecan liposome injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at KO-MED Centra Kliniczne
The vast majority of trials in "KO-MED Centra Kliniczne" are
4 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at KO-MED Centra Kliniczne
Currently, there are NaN active trials in "KO-MED Centra Kliniczne".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in KO-MED Centra Kliniczne,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in KO-MED Centra Kliniczne, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".